[ Citation in PubMed ] [ Related Articles ]
Hava-Shifra Weinberg,1 Eviatar Nevo,1 Abraham Korol,1 Tzion Fahima,1 Gad Rennert,2 and Semion Shapiro2
1Institute of Evolution, University of Haifa, Mount Carmel, Haifa, Israel; 2National Kupat Holim Cancer Control Center, Carmel Medical Center and Technion Faculty of Medicine, Haifa, Israel
Key words: Chernobyl, de novo mutations, liquidators, RAPD PCR, AP PCR, PAGE, silver staining
This paper is based on a presentation at the International Conference on Radiation and Health held 3-7 November 1996 in Beer Sheva, Israel. Abstracts of these papers were previously published in Public Health Reviews 24(3-4):205-431 (1996). Manuscript received at EHP 7 April 1997; accepted 30 June 1997.This work is part of the Ph.D. thesis of H. Weinberg. We are grateful for the financial support of the Authority for Advanced Study at the University of Haifa, to the Israeli Discount Bank Chair of Evolutionary Biology, and the Ancell-Teicher Research Foundation for Genetics and Molecular Evolution.
Address correspondence to Dr. H-S. Weinberg, Institute of Evolution, University of Haifa, Mount Carmel, Haifa 31905, Israel. Telephone: 9724 8240448. Fax: 972 4 8246554. E-mail: rabi101@haifa.uvm.ac.il
Abbreviations used: AP PCR, arbitrarily primed PCR; PCR, polymerase chain reaction; RAPD PCR, random amplified polymorphic DNA PCR; SS, silver staining; SSR, simple sequence repeat.
Last Update: February 17, 1998